Nature-Throid recalled over manufacturing violations
- Recall date
- August 25, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- RLC Labs Inc. recalls Nature-Throid, Thyroid USP [liothyronine (T3) 22.5 mcg and levothyroxine (T4) 95 mcg], 2.5 Grain (162.5 mg) Tablets, pa…
- Recall number
- D-1604-2020
- FDA classification
- Class II
- Brand / firm
- RLC Labs Inc.
- Sold / distributed
- Nationwide in the United States
Why it was recalled
CGMP Deviations: manufactured under the same conditions as those found to be subpotent.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Nature-Throid, Thyroid USP [liothyronine (T3) 22.5 mcg and levothyroxine (T4) 95 mcg], 2.5 Grain (162.5 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3310-4; b) 60-count bottles, NDC 64727-3310-5; c) 90-count bottles, NDC 64727-3310-6; d) 100-count bottles, NDC 64727-3310-1; and e) 1,000-count bottles, NDC 64727-3310-2; Rx only, Manufactured by: RLC Labs Phoenix, AZ 85034.
Get recall alerts
Free email alert whenever RLC Labs Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: RLC Labs Inc.